Insulin, fast-acting (human)

PheWeb

INSULIN_SHORT_HUMAN

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC A10AB01

6047

Check pre-conditions, main-only, mode, ICD version None

5321

Check minimum number of events

Min. number of events 3

5321

Include endpoints None

5321

INSULIN_SHORT_HUMAN

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Insulin, fast-acting (human) based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	5212	2581	2631
Unadjusted prevalence (%)	1.69	1.49	1.95
Mean age at first event (years)	29.12	27.99	30.23

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.04	3.30 [2.36, 4.62]	3.3e-12	733
15 years	0.02	2.58 [1.96, 3.38]	8.7e-12	368
5 years	0.00	3.30 [2.58, 4.22]	2.2e-21	125
1 year	0.00	2.26 [1.34, 3.81]	2.1e-3	16

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: INSULIN_SHORT_HUMAN – Insulin, fast-acting (human)
GWS hits:

Survival analyses between endpoints

↥

Plot

before Insulin, fast-acting (human)
after Insulin, fast-acting (human)

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Insulin, fast-acting (human)

↥